Literature DB >> 35812069

Effect of natural flavonoids to reverse P-glycoprotein-related multidrug resistance in breast cancer cell cultures.

Miglė Paškevičiūtė1, Vilma Petrikaitė1,2.   

Abstract

The aim of the research was to evaluate the influence of two P-glycoprotein (P-gp) inhibitors silymarin and quercetin on anticancer drug doxorubicin (DOX) and pegylated liposomal doxorubicin (PLD) delivery into breast cancer cells (2D cultures) and cancer cell spheroids (3D cultures) at different pH. The cytotoxicity of the compounds was assessed using MTT assay. Spheroids were generated using magnetic 3D Bioprinting method. The uptake of DOX and PLD into monolayer-cultured cells and spheroids was assessed by fluorescence microscopy. Both tested flavonoids did not increase DOX and PLD levels into monolayer-cultured 4T1 cells and 4T1 cell spheroids. However, both silymarin and quercetin enhanced DOX and PLD uptake into JC cell cultures. Silymarin and quercetin may modulate DOX and PLD transport into monolayer-cultured cells and three-dimensional cancer cell cultures depending on P-gp activity. AJCR
Copyright © 2022.

Entities:  

Keywords:  Drug delivery; P-glycoprotein; cell spheroids; multidrug resistance; quercetin; silymarin

Year:  2022        PMID: 35812069      PMCID: PMC9251692     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   5.942


  27 in total

1.  P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808.

Authors:  Jonathan E Kolitz; Stephen L George; Guido Marcucci; Ravi Vij; Bayard L Powell; Steven L Allen; Daniel J DeAngelo; Thomas C Shea; Wendy Stock; Maria R Baer; Vera Hars; Kati Maharry; Eva Hoke; James W Vardiman; Clara D Bloomfield; Richard A Larson
Journal:  Blood       Date:  2010-06-03       Impact factor: 22.113

2.  Two repeated low doses of doxorubicin are more effective than a single high dose against tumors overexpressing P-glycoprotein.

Authors:  Chiara Riganti; Elena Gazzano; Giulia Rossana Gulino; Marco Volante; Dario Ghigo; Joanna Kopecka
Journal:  Cancer Lett       Date:  2015-02-11       Impact factor: 8.679

3.  Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine.

Authors:  A Sparreboom; J van Asperen; U Mayer; A H Schinkel; J W Smit; D K Meijer; P Borst; W J Nooijen; J H Beijnen; O van Tellingen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

4.  Multiple Drug Transport Pathways through Human P-Glycoprotein.

Authors:  James W McCormick; Pia D Vogel; John G Wise
Journal:  Biochemistry       Date:  2015-07-10       Impact factor: 3.162

5.  Acute exposure to doxorubicin results in increased cardiac P-glycoprotein expression.

Authors:  Thomas Budde; Jeanette Haney; Sandra Bien; Matthias Schwebe; Alexander Riad; Carsten Tschöpe; Alexander Staudt; Gabriele Jedlitschky; Stephan B Felix; Heyo K Kroemer; Markus Grube
Journal:  J Pharm Sci       Date:  2011-05-17       Impact factor: 3.534

6.  P-Glycoprotein Overexpression Is Associated With Cisplatin Resistance in Human Osteosarcoma.

Authors:  Chao He; Zhenyu Sun; Robert M Hoffman; Zhijian Yang; Yuhang Jiang; Lei Wang; Yongqiang Hao
Journal:  Anticancer Res       Date:  2019-04       Impact factor: 2.480

7.  Codelivery of chemotherapeutics via crosslinked multilamellar liposomal vesicles to overcome multidrug resistance in tumor.

Authors:  Yarong Liu; Jinxu Fang; Kye-Il Joo; Michael K Wong; Pin Wang
Journal:  PLoS One       Date:  2014-10-17       Impact factor: 3.240

8.  Interaction of docetaxel ("Taxotere") with human P-glycoprotein.

Authors:  K Shirakawa; K Takara; Y Tanigawara; N Aoyama; M Kasuga; F Komada; T Sakaeda; K Okumura
Journal:  Jpn J Cancer Res       Date:  1999-12

Review 9.  Overcoming Multidrug Resistance: Flavonoid and Terpenoid Nitrogen-Containing Derivatives as ABC Transporter Modulators.

Authors:  Bruno M F Gonçalves; David S P Cardoso; Maria-José U Ferreira
Journal:  Molecules       Date:  2020-07-24       Impact factor: 4.411

10.  Quercetin potentiates doxorubicin mediated antitumor effects against liver cancer through p53/Bcl-xl.

Authors:  Guanyu Wang; Jiawei Zhang; Luying Liu; Sherven Sharma; Qinghua Dong
Journal:  PLoS One       Date:  2012-12-11       Impact factor: 3.240

View more
  1 in total

1.  5-FU and the dietary flavonoid carvacrol: a synergistic combination that induces apoptosis in MCF-7 breast cancer cells.

Authors:  Saleh Azimi; Hamed Esmaeil Lashgarian; Vajihe Ghorbanzadeh; Ayat Moradipour; Lale Pirzeh; Hassan Dariushnejad
Journal:  Med Oncol       Date:  2022-10-12       Impact factor: 3.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.